Phoenix Holdings »

Celldex Therapeutics shares owned by Phoenix Holdings

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Phoenix Holdings from 13F filings

Historical chart of Phoenix Holdings investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Phoenix Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Phoenix Holdings

Quarter filed Position value Share count Share price at filing
2024-12-31 $243k 9.6k 25.27

More positions owned by Phoenix Holdings

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Ishares Tr Msci Acwi Etf (ACWI)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Select Sector Spdr Tr Indl (XLI)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Select Sector Spdr Tr Technology (XLK)
Chesapeake Energy Corp (EXE)
Ishares Tr Expanded Tech (IGV)
Ishares Tr U.s. Finls Etf (IYF)

View all positions for Phoenix Holdings

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Point72 Asset Management
Bellevue Group
Commodore Capital
State Street Corporation
Deep Track Capital
Eventide Asset Management
Geode Capital Management
Polar Capital Holdings
Pictet Asset Management Holding SA
Vestal Point Capital

View all funds holding Celldex Therapeutics